Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 12, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 40
- −2 vs. Q1 2026
- Portfolio value
- $461.0M
- +$37.5M (+8.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BMYBristol Myers Squibb Co | Stock | 726,115 | $41.8M | 9.1% | −101,786−12.3% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 217,008 | $27.9M | 6.0% | −43,332−16.6% | Reduced | History |
| MDTMedtronic plc | Stock | 352,437 | $27.6M | 6.0% | +71,755+25.6% | Added | History |
| PFEPfizer Inc | Stock | 1,004,215 | $24.2M | 5.2% | −87,170−8.0% | Reduced | History |
| INCYIncyte Corp | COM | 170,753 | $19.4M | 4.2% | −29,757−14.8% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 44,499 | $17.2M | 3.7% | +537+1.2% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 294,918 | $16.9M | 3.7% | +55,000+22.9% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 33,584 | $16.8M | 3.7% | +33,584 | New | History |
| CVSCVS Health Corp | Stock | 155,337 | $16.1M | 3.5% | +20,000+14.8% | Added | History |
| IQVIQVIA Holdings Inc. | Stock | 77,944 | $15.1M | 3.3% | +37,714+93.7% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 189,468 | $15.0M | 3.3% | +20,000+11.8% | Added | History |
| BDXBecton Dickinson & Co | Stock | 93,168 | $14.1M | 3.1% | +10,553+12.8% | Added | History |
| ABTAbbott Laboratories | Stock | 147,444 | $13.4M | 2.9% | +59,912+68.4% | Added | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 207,863 | $13.3M | 2.9% | +81,445+64.4% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 142,307 | $12.3M | 2.7% | −13,528−8.7% | Reduced | History |
| BIIBBiogen Inc. | COM | 54,163 | $11.7M | 2.5% | −35,933−39.9% | Reduced | History |
| QGENQiagen N.V. | ORD SHARES | 287,640 | $11.2M | 2.4% | +125,269+77.1% | Added | History |
| CNCCentene Corp | Stock | 162,405 | $10.4M | 2.3% | 00.0% | Unchanged | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 15,780 | $9.84M | 2.1% | +15,780 | New | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 33,350 | $9.79M | 2.1% | +9,600+40.4% | Added | History |
| CAHCardinal Health Inc | Stock | 40,689 | $9.67M | 2.1% | −14,208−25.9% | Reduced | History |
| AMGNAmgen Inc | Stock | 26,281 | $9.52M | 2.1% | −20,874−44.3% | Reduced | History |
| BRKRBruker Corp | COM | 152,352 | $9.17M | 2.0% | −101,658−40.0% | Reduced | History |
| AVTRAvantor, Inc. | COM | 906,088 | $8.97M | 1.9% | +210,685+30.3% | Added | History |
| PTCTPTC Therapeutics, Inc. | COM | 100,000 | $8.16M | 1.8% | +25,000+33.3% | Added | History |
| LHLabcorp Holdings Inc. | Stock | 26,019 | $7.29M | 1.6% | +7,000+36.8% | Added | History |
| DXCMDexcom Inc | COM | 102,122 | $6.88M | 1.5% | +46,000+82.0% | Added | History |
| ASNDAscendis Pharma A/S | ORD SHS | 21,305 | $5.68M | 1.2% | 00.0% | Unchanged | History |
| EWEdwards Lifesciences Corp | Stock | 60,402 | $5.46M | 1.2% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 241,739 | $5.28M | 1.1% | −44,268−15.5% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 121,128 | $5.17M | 1.1% | +121,128 | New | History |
| KURAKura Oncology, Inc. | COM | 433,012 | $4.75M | 1.0% | +21,202+5.1% | Added | History |
| TVTXTravere Therapeutics, Inc. | COM | 80,000 | $4.54M | 1.0% | +80,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 114,628 | $4.29M | 0.9% | +20,433+21.7% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 267,091 | $4.03M | 0.9% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 968,466 | $4.03M | 0.9% | +68,466+7.6% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 45,000 | $3.83M | 0.8% | +45,000 | New | History |
| OGNOrganon & Co. | Stock | 270,781 | $3.67M | 0.8% | −105,193−28.0% | Reduced | History |
| ARDXArdelyx, Inc. | COM | 686,844 | $3.50M | 0.8% | +170,713+33.1% | Added | History |
| NTLAIntellia Therapeutics, Inc. | COM | 185,177 | $3.13M | 0.7% | +185,177 | New | History |
Sold out since Q1 2026 (8)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| UNHUnitedHealth Group Inc | Stock | 36,435 | $9.86M | 2.3% | History |
| GILDGilead Sciences, Inc. | Stock | 53,247 | $7.42M | 1.8% | History |
| LNTHLantheus Holdings, Inc. | Stock | 93,344 | $7.08M | 1.7% | History |
| HUMHumana Inc | Stock | 19,202 | $3.33M | 0.8% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 44,263 | $3.29M | 0.8% | History |
| DNLIDenali Therapeutics Inc. | COM | 162,710 | $3.12M | 0.7% | History |
| COGTCogent Biosciences, Inc. | COM | 80,000 | $3.08M | 0.7% | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 30,000 | $1.88M | 0.4% | History |